Pharmaceutical - AstraZeneca

Filter

Current filters:

AstraZeneca

Popular Filters

151 to 175 of 308 results

Alchemia in up to A$240 million deal with AstraZeneca for VAST discovery platform

23-04-2013

In a third drug discovery agreement in a matter of days, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlchemiaAstraZenecaLicensingPharmaceuticalResearch

Horizon Discovery signs cancer drug discovery deal with AstraZeneca

22-04-2013

In a second deal announced today (April 22), Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed…

AstraZenecaHD-001Horizon DiscoveryLicensingOncologyPharmaceuticalResearch

Japan Supreme Court absolves AstraZeneca over deaths associated with Iressa

17-04-2013

The Japanese Supreme Court has upheld high court rulings that the Japanese unit of Anglo-Swedish drug…

Asia-PacificAstraZenecaIressaLegalOncologyPharmaceutical

Briefs: Royalty sweetens offer for Elan; AstraZeneca biomarker deal

16-04-2013

US private equity company Royalty Pharma today (April 15) issued a firm improved takeover offer for Ireland-based…

AstraZenecaElanLicensingMergers & AcquisitionsOncologyOxford Cancer BiomarkersPharmaceuticalResearchRoyalty Pharma

Mixed top-line results for AstraZeneca's RA drug candidate fostamatinib

05-04-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) this morning reported top-line results from the Phase…

Anti-Arthritics/RheumaticsAstraZenecafostamatinibPharmaceuticalResearch

AstraZeneca acquires AlphaCore; Merck Serono links with BioMed X

03-04-2013

In line with its stated policy of targeted acquisitions, Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AlphaCore PharmaAstraZenecaBiotechnologyCardio-vascularMerck KGaAMerck SeronoMergers & AcquisitionsMetabolicsPharmaceuticalResearch

Proposal to list AstraZeneca's Brilinta in New Zealand

26-03-2013

New Zealand's Pharmaceutical Management Agency, PHARMAC, is seeking feedback on a proposal to fund the…

Asia-PacificAstraZenecaBrilintaCardio-vascularFinancialHealthcarePharmaceuticalPricingticagrelor

Positive reception for AstraZeneca recovery strategy

22-03-2013

The marathon eight-hour strategy update presented in New York on Thursday (March 21) by AstraZeneca's…

AstraZenecaFinancialPharmaceuticalResearch

AstraZeneca entices GSK R&D exec to head its Global Portfolio & Product Strategy

21-03-2013

Troubled Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced that Marc Dunoyer is to join the company…

AstraZenecaManagementPharmaceutical

Major overhaul of AstraZeneca R&D sites, and HQ move, will see 1,600 job cuts

19-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN), which is struggling with recent research disappointments…

AstraZenecaFinancialManagementPharmaceuticalResearch

European Patent Office maintains Pozen's PA/Vimovo patent

12-03-2013

US drug firm Pozen (Nasdaq: POZN) says that the Opposition Division of the European Patent Office has…

AstraZenecaEuropeInflammatory diseasesPatentsPharmaceuticalPozenVimovo

Further savings expected following Australian Crestor patent decision, says GMiA

07-03-2013

In a decision brought down by the Australian Federal Court earlier this week, suppliers of generic medicines…

Asia-PacificAstraZenecaCardio-vascularCrestorGenericsPatentsPharmaceuticalPricing

Targacept regains rights to Alzheimer's drug candidate from AstraZeneca

06-03-2013

US biopharma drug developer Targacept (Nasdaq: TRGT) and Anglo-Swedish drug major AstraZeneca (LSE: AZN)…

AstraZenecaAZD1446LicensingNeurologicalPharmaceuticalResearchTargaceptTC-1734

AstraZeneca's Crestor patent rule invalid in Australia

05-03-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that the Federal Court of Australia…

Asia-PacificAstraZenecaCardio-vascularCrestorPatentsPharmaceutical

Encouraging results for AstraZeneca's naloxegol in OIC

26-02-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has announced high-level results from KODIAC-08, an open-label,…

AstraZenecaGastro-intestinalsnaloxegolNeurologicalPharmaceuticalResearch

US Court of Appeals confirms validity of AstraZeneca' Seroquel XR patent

15-02-2013

AstraZeneca announced that, on 14 February 2013, the United States Court of Appeals for the Federal Circuit…

AstraZenecaGenericsLegalNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XR

Negative NICE guidance for Roche's Avastin and B-MS/AstraZeneca's Forxiga

01-02-2013

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has published draft…

AstraZenecaAvastinBristol-Myers SquibbDiabetesEuropeForxigaOncologyPharmaceuticalPricingRegulationRoche

AstraZeneca 2012 results continue to suffer from generic competition

31-01-2013

Anglo-Swedish drug major AstraZeneca (LSE: AZN) revealed this morning that, for full year 2012, revenues…

AstraZenecaFinancialPharmaceutical

Sweden's Orexo in respiratory research accord with AstraZeneca

28-01-2013

Swedish drug developer Orexo AB (STO: ORX) has entered into an agreement with Anglo-Swedish drug major…

AstraZenecaLicensingOrexo ABOX-CLIPharmaceuticalResearchRespiratory and Pulmonary

Positive outlook for Hutchison China MediTech, say analysts

21-01-2013

Analysts at Panmure Gordon & Co say they remain buyers of Hutchison China MediTech (LSE: HCM), which…

AstraZenecaFinancialHutchison MediTechLicensingPharmaceuticalvolitinib

151 to 175 of 308 results

Back to top